In landmark mouse studies, oral 5-amino-1MQ produced robust reductions in adipocyte size, body fat and inflammatory adipokines while leaving food intake unchanged pointing to a fundamentally novel metabolic-rejuvenation mechanism that operates entirely on the methylationNAD axis
You may also notice an improvement in coordination and balance
5-Amino-1MQ, research compound, third party tested, COA available, Disguised Alpha, Encapsulated Products, Solution Preparations 5-Amino-1MQ is commonly positioned around NNMT pathway research, NAD metabolism models, metabolic signaling studies
IV (weekly): 250 mg/week or 500 mg/week , depending on the infusion length/volume
Data indicates that investigators using 5-Amino-1MQ in the same research program as Tirzepatide or Semaglutide often do so to compare signalling breadth, tissue selectivity, or pathway overlap